Recent Articles

3 Beaten-Down Generic Drugmakers to Buy

Generic drugmakers Mylan (MYL), Teva (TEVA) and Novartis (NOV) took a hit from DOJ subpoenas on speculation of price-fixing in the industry. More 

73 Household Names To Sell Right Away

As we approach the end of 2016, now is an excellent time to trim your portfolio of all dead weight. Get started with these 73 stocks to sell More 

Sleepy Johnson & Johnson (JNJ) Stock Could Finally Wake Up

If Johnson & Johnson (JNJ) deals for Actelion, it would be out of character. But it still could be a boon for JNJ stock. More 

This Unlucky Biotech Stock Has Entered The Value-Buy Zone (OPHT)

The volatility of biotech shares makes biotech investing among the most lucrative ways to invest. Here's a great way to start... More 

Avoid These 7 Big-Name Biotechs and Pharmaceuticals

Biotech and pharmaceutical companies headed lower and not because of the election. Here's why you should sell these stocks More 

PFE Stock: Ignore Pfizer Inc.’s Earnings Miss at Your Own Peril

Pfizer missed on earnings, and PFE stock slipped as a result. But even if you don't own Pfizer, you don't want to ignore what's happening there. More 

11 Pharmaceuticals Stocks to Sell Now

The ratings of 11 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More